Clementia Pharmaceuticals, Inc.
(NASDAQ : CMTA)

( )
CMTA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
BMYBristol-Myers Squibb Co.
0.47%62.381.4%$1669.89m
JNJJohnson & Johnson
0.70%140.970.7%$887.68m
PFEPfizer Inc.
-0.70%38.210.9%$742.91m
MRKMerck & Co., Inc.
-0.15%88.970.7%$686.65m
ABBVAbbVie, Inc.
0.15%86.692.3%$623.80m
LLYEli Lilly & Co.
0.11%120.781.1%$357.63m
NVSNovartis AG
0.25%93.030.2%$145.85m
AZNAstraZeneca Plc
0.43%48.191.2%$139.74m
GSKGlaxoSmithKline Plc
0.33%46.300.2%$135.97m
RETAReata Pharmaceuticals, Inc.
-2.72%199.543.5%$132.56m
SNYSanofi
1.91%49.010.2%$100.06m
KRTXKaruna Therapeutics, Inc.
-3.19%64.420.0%$98.93m
NVONovo Nordisk A/S
-0.12%56.870.1%$88.61m
ALLKAllakos, Inc.
0.31%121.260.0%$73.17m
FTSVForty Seven, Inc.
3.77%35.960.0%$42.27m

Company Profile

Clementia is a biopharmaceutical company dedicated to bringing effective new treatments to people who have none. Clementia is rapidly developing its first lead product candidate, palovarotene, to treat fibrodysplasia ossificans progressiva (FOP), an ultra-rare and severely disabling disorder, and other diseases.